Carl Zeiss Meditec (ETR:AFX) Given a €89.00 Price Target at Deutsche Bank

Share on StockTwits

Deutsche Bank set a €89.00 ($103.49) price objective on Carl Zeiss Meditec (ETR:AFX) in a report published on Monday morning, Borsen Zeitung reports. The firm currently has a neutral rating on the stock.

A number of other research firms have also recently weighed in on AFX. HSBC set a €84.00 ($97.67) price objective on shares of Carl Zeiss Meditec and gave the stock a neutral rating in a research report on Monday, June 3rd. Hauck & Aufhaeuser set a €92.50 ($107.56) price objective on shares of Carl Zeiss Meditec and gave the stock a buy rating in a research report on Monday, April 15th. Nord/LB set a €92.00 ($106.98) price objective on shares of Carl Zeiss Meditec and gave the stock a neutral rating in a research report on Wednesday, May 8th. Independent Research set a €88.00 ($102.33) price objective on shares of Carl Zeiss Meditec and gave the stock a sell rating in a research report on Wednesday, July 17th. Finally, Berenberg Bank set a €93.00 ($108.14) price objective on shares of Carl Zeiss Meditec and gave the stock a neutral rating in a research report on Wednesday, July 17th. Two research analysts have rated the stock with a sell rating, five have assigned a hold rating and one has issued a buy rating to the company. The company has a consensus rating of Hold and a consensus target price of €84.06 ($97.75).

Shares of ETR AFX opened at €100.80 ($117.21) on Monday. The business’s 50 day moving average price is €93.22. The firm has a market cap of $9.02 billion and a P/E ratio of 70.29. The company has a debt-to-equity ratio of 4.55, a current ratio of 4.11 and a quick ratio of 3.09. Carl Zeiss Meditec has a 1 year low of €60.25 ($70.06) and a 1 year high of €104.30 ($121.28).

About Carl Zeiss Meditec

Carl Zeiss Meditec AG operates as a medical technology company in Germany, the United States, Japan, other Europe countries, and internationally. It operates through two segments, Ophthalmic Devices and Microsurgery. The Ophthalmic Devices segment offers optical biometers, ophthalmic surgical microscopes, phacoemulsification/vitrectomy devices, intraocular lenses, and ophthalmic viscoelastic products for the diagnosis and treatment of ophthalmic diseases in the field of cataract and retinal surgery.

Featured Story: Intrinsic Value

Analyst Recommendations for Carl Zeiss Meditec (ETR:AFX)

Receive News & Ratings for Carl Zeiss Meditec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Carl Zeiss Meditec and related companies with MarketBeat.com's FREE daily email newsletter.



Latest News

Potlatchdeltic  Raised to Strong-Buy at ValuEngine
Potlatchdeltic Raised to Strong-Buy at ValuEngine
IHS Markit  Earns Buy Rating from Analysts at Canaccord Genuity
IHS Markit Earns Buy Rating from Analysts at Canaccord Genuity
eHealth  Earns Buy Rating from Analysts at Deutsche Bank
eHealth Earns Buy Rating from Analysts at Deutsche Bank
Healthequity  Earns Buy Rating from Analysts at Deutsche Bank
Healthequity Earns Buy Rating from Analysts at Deutsche Bank
JPMorgan Chase & Co. Raises Casey’s General Stores  Price Target to $169.00
JPMorgan Chase & Co. Raises Casey’s General Stores Price Target to $169.00
Activision Blizzard  Raised to Buy at Nomura
Activision Blizzard Raised to Buy at Nomura


© 2006-2019 Ticker Report